Screener
Evolent Health, Inc. EVH Reportable segment — Interest Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses | 662,081 | 445,499 | 1,168,926 | 930,770 |
| Operating loss | (9,561) | (1,171) | (20,160) | (2,793) |
| Interest income | 703 | 1,084 | 1,717 | 2,358 |
| Interest expense | (16,859) | (11,601) | (33,727) | (21,986) |
| Gain (loss) from equity method investees | (41) | 197 | (52) | 178 |
| Loss on option exercise | — | (196) | — | (52,544) |
| Extinguishment of Series A Preferred Stock and other refinancing fees | — | (9,000) | — | (9,000) |
| Other income (expense), net | 109 | (35) | 851 | (83) |
Item 1. Financial Statements
FAQ
- What is Evolent Health, Inc.'s reportable segment — interest expense?
- Evolent Health, Inc. (EVH) reported reportable segment — interest expense of $16.86M in Q2 2026.
- How has Evolent Health, Inc.'s reportable segment — interest expense changed year-over-year?
- Evolent Health, Inc.'s reportable segment — interest expense increased by 45.3% year-over-year, from $11.6M to $16.86M.
- What is the long-term trend for Evolent Health, Inc.'s reportable segment — interest expense?
- Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — interest expense has grown at a 54.5% compound annual growth rate (CAGR), from $15.57M to $57.47M.
- What does reportable segment — interest expense mean?
- This captures the costs associated with the segment's debt obligations and financing arrangements. It is a key metric for evaluating the segment's financial leverage and the impact of debt servicing on overall profitability.
Ask your AI about Evolent Health, Inc.'s reportable segment — interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude